Baclofen pump for children with cerebral palsy and dystonia
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study tests if a pump that delivers baclofen directly into the spinal fluid can help children with cerebral palsy who have severe dystonia (uncontrolled muscle tightness). It looks at how well the treatment works and tracks progress over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be at least 4 years old and weigh about 40 pounds or more to have the pump placed.
- Your child must have a diagnosis of cerebral palsy (CP).
- Your child must have dystonia that is moderate to severe, as confirmed by a doctor's assessment.
- A doctor has already recommended the baclofen pump for muscle control, and you and your child agree to move forward.
- You and your child must be willing to attend all study visits before the pump is placed, every 2 weeks until the right dose is found, and then for follow-up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether deep brain stimulation (a small device placed in the brain that sends electrical pulses) can help improve movement problems in children and young adults with a certain type of cerebral palsy. The goal is to see if it can reduce involuntary movements like twisting or jerking.
This study looks at factors that might predict how well a treatment called ITB works for children and teens with cerebral palsy (CP). It may help doctors better understand who is most likely to benefit from ITB.
This study tests whether a Botox (botulinum toxin) injection can improve arm and leg movement in children with cerebral palsy. It is for kids ages 8–17 who have stiffness mainly on one side and can walk well.
This study looks at how botulinum toxin injections affect the muscles of children with spastic cerebral palsy, comparing them to typically developing children to understand the balance between treatment benefits and potential muscle damage.
This trial tests if a treatment called ITB (intrathecal baclofen) can help reduce muscle stiffness in people with hereditary spastic paraplegia (HSP). Participants will receive the treatment and be followed over time to see how well it works.
This study checks whether a special device can reliably measure muscle stiffness and spasticity (tight, overactive muscles) in children. It includes children with cerebral palsy and healthy children to compare measurements and improve accuracy.
Hear when a new Dystonic Cerebral Palsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.